At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash. - BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc. - CardioNet, Inc. based in San Diego, USA was initially founded in 1994. - After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this
Read More
Signify Research | Healthcare Technology Market Intelligence
Will Nanox Disrupt The X-Ray Systems Market?
With its share price falling from more than $66 to less than $24, September was a tumultuous month for Nanox. On August 25th, the medical imaging start-up closed its initial public offering, having raised $190m from the sale of 10,555,556 ordinary shares at a price of $18 each. Money poured in as investors were sold on Nanox’s cold cathode x-ray source and the subsequent reduction in costs that it would enable, as well as the vendor’s pay-per-scan pricing model that would let the company
Read More
The Future of the ICU? How Clinical Decision Support Is Advancing Care
Without a doubt 2020 has been a devastating year for many; the impact of COVID-19 on both personal lives and businesses has had long-term consequences. At the end of September, the number of COVID-19 cases fell just short of 350 million, with just over 1 million deaths reported. The expectation of a second peak in many countries exposed to the deadly illness is being handled with care, with many governments attempting to minimize the impact of an extreme rise in cases. COVID-19
Read More
AmWell IPO and Google Deal – Five Key Takeaways to Know
1) COVID-19 Has Driven Revenue Up 77% The headline revenue data (summarised below) provides very positive news for AmWell and its new investor, Google. Notably: - Even prior to COVID-19, the company was growing well with revenues increasing by 31% in 2019 compared to 2018. - This rate of growth has accelerated in 1H20, with overall revenue up 77% in the same period in 2019. - The 2019 growth was partly driven by a small increase in the number of health plan subscription customers and
Read More
Why International Expansion Must Remain a Priority for Cerner, Epic, Allscripts, MEDITECH
What You Should Know: - How the top US acute EHR vendors, namely Cerner, Epic, Allscripts, and MEDITECH (+85% share of US acute market in terms of revenues), have progressed on international expansion. As highlighted below, there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $650M in 2019, representing 12% of its business. Whilst MEDITECH has considerably lower revenue than
Read More
M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical
What You Should Know: - Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. - Deal expected to close in 1H 2021. - Varian Medical will maintain its brand name and operate “independently” - Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as part of the transaction. News of the deal between Siemens Healthineers and Varian Medical will have caught many industry onlookers off guard on Sunday evening.
Read More
M&A Analysis: Mednax to Sell its Radiology and Teleradiology Business
Earlier this month saw Mednax announce significant plans to transform its business. Mednax intends to: - Sell its Mednax Radiology Solutions business, which includes its radiology groups and the teleradiology market leader Virtual Radiologic (vRad). - Reposition itself as a dedicated pediatrics and obstetrics business, including a return to its original company name, Pediatrix Medical Group. Mednax made its entrance into the radiology business following the $500m acquisition of vRad in
Read More
COVID-19 and Its Global Impact on Primary Care Virtual Consultations
Last week saw Teladoc Health release its 1Q20 financial results giving the US telehealth industry a first glimpse of how COVID-19 is impacting the ambulatory virtual care market. Discussion around the crisis and its impact on telehealth has been rife since early March and the data published by Teladoc Health highlights that this was justified. The company reported that the number of virtual care consults in the quarter had passed the 2 million mark, up approximately 60% from the 1.24M
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?
On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market: - The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio. - TeraRecon is an Advanced
Read More
